Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03623139
Other study ID # H-18014918
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date September 28, 2018
Est. completion date August 16, 2022

Study information

Verified date April 2023
Source Steno Diabetes Center Copenhagen
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The aim of the study is to examine the health benefits of adding a concept in basic carbohydrate counting (BCC) to the routine outpatient nutritional education for adult patients with type 2 diabetes. The study hypothesis is that training and education in the BCC concept will improve glycaemic control either by reducing HbA1c or the average plasma glucose variability more than offering the routine dietary care as a stand-alone dietary treatment.


Description:

The trial has a parallel-group design with a study duration of 48 weeks for each participant (a 6-month intervention period and a 6-month follow-up period). A total of 226 patients will be enrolled in the trial. Participants will be randomized to one of two arms: 1) Standard medical and dietary care (control group) or 2) Structured training and education in the BCC concept in addition to standard medical and dietary care. The primary objective is to evaluate the six months effect of structured training and education in the BCC concept compared to standard dietary care on glycaemic control as assessed by HbA1c or MAGE (mean amplitude of glycaemic excursions).


Recruitment information / eligibility

Status Completed
Enrollment 48
Est. completion date August 16, 2022
Est. primary completion date August 16, 2022
Accepts healthy volunteers No
Gender All
Age group 18 Years to 75 Years
Eligibility Inclusion Criteria: - Type 2 diabetes - Diabetes duration; from >12 months - HbA1c between 53 and 97 mmol/mol - Diet or any glucose-lowering medication - Provided voluntary written informed consent Exclusion Criteria: - Practicing carbohydrate counting, as judged by the investigator - Participated in a BCC group program within the last two years - Low daily intake of carbohydrates (defined as below 25 E% or 100 g/day), as judged by the investigator - Use of open CGM - Use of a Free Libre device - Use of an automated bolus calculator for carbohydrate counting, as judged by the investigator - Gastroparesis - Pregnancy or breastfeeding, or plans of pregnancy within the study period - Uncontrolled medical issues, as judged by the investigator - Concomitant participation in other clinical studies - Unable to understand the informed consent and the study procedures

Study Design


Intervention

Behavioral:
Standard nutritional education
Routine dietary care consists of three individual consultations with a trained dietitian. The individual guidance will be in accordance with the dietary guidelines in type 2 diabetes.
Basic carbohydrate counting
The BCC concept is a group-based program consisting of three group sessions delivered by trained dietitians.

Locations

Country Name City State
Denmark Steno Diabetes Center Copenhagen Herlev

Sponsors (2)

Lead Sponsor Collaborator
Steno Diabetes Center Copenhagen University of Copenhagen

Country where clinical trial is conducted

Denmark, 

Outcome

Type Measure Description Time frame Safety issue
Other Change in physical activity level total score or percent (%) Baseline, 6 months, 12 months
Other Change in urinary biomarkers of carbohydrate intake percent (%) Baseline, 6 months
Primary Change in HbA1c mmol/mol Baseline, 6 months
Primary Change in mean amplitude of glycaemic excursions (MAGE) mmol/l Baseline, 6 months
Secondary Change in HbA1c mmol/mol 12 months
Secondary Change in body weight kg Baseline, 6 months, 12 months
Secondary Change in low-density lipoprotein cholesterol (LDL-C) mmol/l Baseline, 6 months, 12 months
Secondary Change in high-density cholesterol (HDL-C) mmol/l Baseline, 6 months, 12 months
Secondary Change in total cholesterol (TC) mmol/l Baseline, 6 months, 12 months
Secondary Change in free fatty acids (FFA) mmol/l Baseline, 6 months, 12 months
Secondary Change in triglycerides (TG) mmol/l Baseline, 6 months, 12 months
Secondary Change in diastolic blood pressure mm Hg Baseline, 6 months, 12 months
Secondary Change in systolic blood pressure mm Hg Baseline, 6 months, 12 months
Secondary Change in waist circumference cm Baseline, 6 months, 12 months
Secondary Change in hip circumference cm Baseline, 6 months, 12 months
Secondary Change in total fat free mass gram Baseline, 6 months
Secondary Change in total fat mass gram Baseline, 6 months
Secondary Change in time in range (3.9-10.0 mmol/l) percent (%) Baseline, 6 months
Secondary Changes in time spent in hypoglycaemia (<3.9 mmol/l) percent (%) Baseline, 6 months
Secondary Change time spent in hyperglycaemia (e.g. >11.1 mmol/l) percent (%) Baseline, 6 months
Secondary Change in standard deviation of mean plasma glucose mmol/l Baseline, 6 months
Secondary Change in mathematical literacy total score or percent (%) Baseline, 6 months, 12 months
Secondary Change in carbohydrate estimation accuracy total score or % Baseline, 6 months, 12 months
Secondary Change in diet-related quality of life total score or percent (%) Baseline, 6 months, 12 months
Secondary Change in perceived competences in diabetes total score or percent (%) Baseline, 6 months, 12 months
Secondary Change in degree of autonomy-supportive dietitian total score or percent (%) Baseline, 6 months, 12 months
Secondary Change in total energy intake kJ/day Baseline, 6 months
Secondary Change in dietary intake of carbohydrates gram/day or percent of total energy (E%) Baseline, 6 months
Secondary Change in dietary intake of total fat gram/day or percent of total energy (E%) Baseline, 6 months
Secondary Change in dietary intake of saturated fatty acids (SFA) gram/day or percent of total energy (E%) Baseline, 6 months
Secondary Change in dietary intake of monounsaturated fatty acids (MUFA) gram/day or percent of total energy (E%) Baseline, 6 months
Secondary Change in dietary intake of polyunsaturated fatty acids (PUFA) gram/day or percent of total energy (E%) Baseline, 6 months
Secondary Change in dietary intake of protein gram/day or percent of total energy (E%) Baseline, 6 months
Secondary Change in dietary intake of added sugar gram/day , % of total energy or % Baseline, 6 months
Secondary Change in intake of dietary fibre gram/day or g/MJ Baseline, 6 months
See also
  Status Clinical Trial Phase
Active, not recruiting NCT05666479 - CGM Monitoring in T2DM Patients Undergoing Orthopaedic Replacement Surgery
Completed NCT05647083 - The Effect of Massage on Diabetic Parameters N/A
Active, not recruiting NCT05661799 - Persistence of Physical Activity in People With Type 2 Diabetes Over Time. N/A
Completed NCT03686722 - Effect of Co-administration of Metformin and Daclatasvir on the Pharmacokinetis and Pharmacodynamics of Metformin Phase 1
Completed NCT02836704 - Comparison of Standard vs Higher Starting Dose of Insulin Glargine in Chinese Patients With Type 2 Diabetes (Glargine Starting Dose) Phase 4
Completed NCT01819129 - Efficacy and Safety of FIAsp Compared to Insulin Aspart in Combination With Insulin Glargine and Metformin in Adults With Type 2 Diabetes Phase 3
Completed NCT04562714 - Impact of Flash Glucose Monitoring in People With Type 2 Diabetes Using Non-Insulin Antihyperglycemic Therapy N/A
Completed NCT02009488 - Treatment Differences Between Canagliflozin and Placebo in Insulin Secretion in Subjects With Type 2 Diabetes Mellitus (T2DM) Phase 1
Completed NCT05896319 - Hyaluronic Acid Treatment of the Post-extraction Tooth Socket Healing in Subjects With Diabetes Mellitus Type 2 N/A
Recruiting NCT05598203 - Effect of Nutrition Education Groups in the Treatment of Patients With Type 2 Diabetes N/A
Completed NCT05046873 - A Research Study Looking Into Blood Levels of Semaglutide and NNC0480-0389 When Given in the Same Injection or in Two Separate Injections in Healthy People Phase 1
Terminated NCT04090242 - Impact of App Based Diabetes Training Program in Conjunction With the BD Nano Pen Needle in People With T2 Diabetes N/A
Completed NCT04030091 - Pulsatile Insulin Infusion Therapy in Patients With Type 1 and Type 2 Diabetes Mellitus Phase 4
Completed NCT03620357 - Continuous Glucose Monitoring & Management In Type 2 Diabetes (T2D) N/A
Completed NCT03604224 - A Study to Observe Clinical Effectiveness of Canagliflozin 300 mg Containing Treatment Regimens in Indian Type 2 Diabetes Participants With BMI>25 kg/m^2, in Real World Clinical Setting
Completed NCT01696266 - An International Survey on Hypoglycaemia Among Insulin-treated Patients With Diabetes
Completed NCT03620890 - Detemir Versus NPH for Type 2 Diabetes Mellitus in Pregnancy Phase 4
Withdrawn NCT05473286 - A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Germany, as Part of Local Clinical Practice
Not yet recruiting NCT05029804 - Effect of Walking Exercise Training on Adherence to Disease Management and Metabolic Control in Diabetes N/A
Completed NCT04531631 - Effects of Dorzagliatin on 1st Phase Insulin and Beta-cell Glucose Sensitivity in T2D and Monogenic Diabetes Phase 2